ArticlePrecision nanomedicine2018

Nanoparticle-Encapsulated Doxorubicin Demonstrates Superior Tumor Cell Kill in Triple Negative Breast Cancer Subtypes Intrinsically Resistant to Doxorubicin.

Aimee E Krausz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.